Preoperative Combined with Postoperative Chemoembolization Can Improve Survival in Patients with Hepatocellular Carcinoma: A Single-center Study

Journal of Vascular and Interventional Radiology

Volumn 20, Issue 4, 2009, Pages 472-483

  Liu, YuJin ^a   Yang, RenJie ^a  

^a PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; EPIRUBICIN; FLUOROURACIL; IODINATED POPPYSEED OIL; MITOMYCIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHEMOEMBOLIZATION; CONTROLLED STUDY; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE;

ADOLESCENT; ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; CHINA; COMBINED MODALITY THERAPY; FEMALE; HUMANS; INCIDENCE; LIVER NEOPLASMS; MALE; MIDDLE AGED; POSTOPERATIVE CARE; PREOPERATIVE CARE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 62749126409     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvir.2009.01.011     Document Type: Article

References (30)

1. Llovet J.M., Bruix J., and Barcelona-Clinic Liver Cancer Group. Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 37 (2003) 429-442
2. Llovet J.M., Burroughs A., and Bruix J. Hepatocellular carcinoma. Lancet 362 (2003) 907-917
3. Shah S.A., Greig P.D., Gallinger S., et al. Factors associated with early recurrence after resection for hepatocellular carcinoma and outcomes. J Am Coll Surg 202 (2006) 275-283
4. Adachi E., Matsumata T., Nishizaki T., Hashimoto H., Tsuneyoshi M., and Sugimachi K. Effects of preoperative TACE for HCC - the relationship between postoperative course and tumor necrosis. Cancer 72 (1993) 3593-3598
5. Wu C.C., Ho Y.Z., Lin H.W., Wu T.C., Liu T.J., and Peng F.K. Preoperative transcatheter arterial chemoembolization for resectable large hepatocellular carcinoma: a reappraisal. Br J Surg 82 (1995) 122-126
6. Yamasaki S., Hasegawa H., Kinoshita H., et al. A prospective randomized trial of the preventive effect of pre-operative transcatheter arterial embolization against recurrence of hepatocellular carcinoma. Jpn J Cancer Res 87 (1996) 206-211
7. Hanazaki K., Kajikawa S., Shimozawa N., et al. Survival and recurrence after hepatic resection of 386 consecutive patients with hepatocellular carcinoma. J Am Coll Surg 191 (2000) 381-388
8. Kim I.S., Lim Y.S., Lee H.C., Suh D.J., Lee Y.J., and Lee S.G. Pre-operative transarterial chemoembolization for resectable hepatocellular carcinoma adversely affects post-operative patient outcome. Aliment Pharmacol Ther 27 (2008) 338-345
9. Yu Y.Q., Xu D.B., Zhou X.D., Lu J.Z., Tang Z.Y., and Mack P. Experience with liver resection after hepatic arterial chemoembolization for hepatocellular carcinoma. Cancer 71 (1993) 62-65
10. Lu C.D., Peng S.Y., Jiang X.C., Chiba Y., and Tanigawa N. Preoperative transcatheter arterial chemoembolization and prognosis of patients with hepatocellular carcinomas: retrospective analysis of 120 cases. World J Surg 23 (1999) 293-300
11. Zhang Z., Liu Q., He J., Yang J., Yang G., and Wu M. The effect of preoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcinoma. Cancer 89 (2000) 2606-2612
12. Gerunda G.E., Neri D., Merenda R., et al. Role of transarterial chemoembolization before liver resection for hepatocarcinoma. Liver Transplant 6 (2000) 619-626
13. Sugo H., Futagawa S., Beppu T., Fukasawa M., and Kojima K. Role of preoperative transcatheter arterial chemoembolization for resectable hepatocellular carcinoma: relation between postoperative course and the pattern of tumor recurrence. World J Surg 27 (2003) 1295-1299
14. Parikh S., and Hyman D. Hepatocellular cancer: a guide for the internist. Am J Med 120 (2007) 194-202
15. Ryder S.D. Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults. Gut 52 suppl III (2003) iii1-iii8
16. Poon R.T.P., Fan S.T., Lo C.M., et al. Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years. Ann Surg 234 (2001) 63-70
17. Mathurin P., Raynard B., Dharancy S., et al. Meta-analysis: evaluation of adjuvant therapy after curative liver resection for hepatocellular carcinoma. Aliment Pharmacol Ther 17 (2003) 1247-1261
18. Portolani N., Coniglio A., Ghidoni S., et al. Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications. Ann Surg 243 (2006) 229-235
19. Lo C.M., Ngan H., Tso W.K., et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 35 (2002) 1164-1171
20. Llovet J.M., Real M.I., Montana X., et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular. Lancet 359 (2002) 1734-1739
21. Graziadei I.W., Sandmueller H., Waldenberger P., et al. Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome. Liver Transplant 9 (2003) 557-563
22. Hayashi P.H., Ludkowski M., Forman L.M., et al. Hepatic artery chemoembolization for hepatocellular carcinoma in patients listed for liver transplantation. Am J Transplant 4 (2004) 782-787
23. Matsui O., Kadoya M., Yoshikawa J., et al. Small hepatocellular carcinoma: treatment with subsegmental transcatheter arterial embolization. Radiology 188 (1993) 79-83
24. Huo T.I., Huang Y.H., Wu J.C., Lee P.C., Chang F.Y., and Lee S.D. Induction of complete tumor necrosis may reduce intrahepatic metastasis and prolong survival in patients with hepatocellular carcinoma undergoing locoregional therapy: a prospective study. Ann Oncol 15 (2004) 775-780
25. Miyayama S., Matsui O., Yamashiro M., et al. Ultraselective transcatheter arterial chemoembolization with a 2-F tip microcatheter for small hepatocellular carcinomas: relationship between local tumor recurrence and visualization of the portal vein with iodized oil. J Vasc Interv Radiol 18 (2007) 365-376
26. Susumu E., Shigehiro M., Koji H., et al. Re-evaluation of lipiodolized transarterial chemoembolization therapy for intrahepatic recurrence of hepatocellular carcinoma after curative liver resection. J Hepatobiliary Pancreat Surg 15 (2008) 627-633
27. Sasaki A., Iwashita Y., Shibata K., Matsumoto T., Ohta M., and Kitano S. Improved long-term survival after liver resection for hepatocellular carcinoma in the modern era: retrospective study from HCV-endemic areas. World J Surg 30 (2006) 1567-1578
28. Salem R., Lewandowski R., Roberts C., et al. Use of yttrium-90 glass microspheres (TheraSphere) for the treatment of unresectable hepatocellular carcinoma in patients with portal vein thrombosis. J Vasc Interv Radiol 15 (2004) 335-345
29. Kumar A., Srivastava D.N., Minh Chau T.T., et al. Inoperable hepatocellular carcinoma: transarterial 188Re HDD-labeled iodized oil for treatment-prospective multicenter clinical trial. Radiology 243 (2007) 509-519
30. Brown D.B., Gould J.E., Gervais D.A., et al. Transcatheter therapy for hepatic malignancy: standardization of terminology and reporting criteria. J Vasc Interv Radiol 18 (2007) 1469-1478